Cara Therapeutics, Inc.
NASDAQ:CARA
0.2918 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 52.183 | 63.741 | 13.453 | 31.683 | 18.305 | 15.081 | 9.388 | 12.092 | 15.101 | 52.663 | 12.357 | 1.117 | 4.097 |
| Short Term Investments
| 48.983 | 81.658 | 153.582 | 149.242 | 136.701 | 146.302 | 83.181 | 46.184 | 91.64 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 101.166 | 145.399 | 167.035 | 180.925 | 155.006 | 161.383 | 92.569 | 58.276 | 106.741 | 52.663 | 12.357 | 1.117 | 4.097 |
| Net Receivables
| 4.017 | 4.453 | 1.152 | 2.064 | 1.787 | 1.59 | 0.854 | 0.939 | 0.464 | 0.2 | 0.061 | 0.031 | 0.057 |
| Inventory
| 2.821 | 2.383 | 2.584 | -1.507 | -0.816 | 0 | 0 | 0 | 0 | 0 | 0.034 | 0 | 0 |
| Other Current Assets
| 8.154 | 16.675 | 2.519 | 13.583 | 9.679 | 5.166 | 1.635 | 2.23 | 1.729 | 0.287 | 2.106 | 0.08 | 0.404 |
| Total Current Assets
| 116.158 | 168.91 | 173.29 | 195.065 | 165.656 | 168.139 | 95.058 | 61.445 | 108.934 | 53.15 | 14.558 | 1.228 | 4.558 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 8.186 | 1.977 | 3.604 | 5.119 | 3.736 | 0.88 | 1.177 | 1.614 | 1.263 | 2.084 | 2.825 | 3.609 | 5.427 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.5 | 11.35 | 69.754 | 70.565 | 63.159 | 21.396 | 0.769 | 0.769 | 0.7 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | -13.327 | 0.408 | 0.408 | 0.408 | 0.408 | 0 | 0 | 0 | 0.7 | 0.7 | 0.7 | 0.7 |
| Total Non-Current Assets
| 9.686 | 13.327 | 73.766 | 76.092 | 67.303 | 22.684 | 1.946 | 2.383 | 1.963 | 2.784 | 3.525 | 4.309 | 6.127 |
| Total Assets
| 125.844 | 182.237 | 247.056 | 271.157 | 232.959 | 190.823 | 97.004 | 63.828 | 110.897 | 55.934 | 18.083 | 5.537 | 10.685 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 11.583 | 9.604 | 5.625 | 4.893 | 9.1 | 4.371 | 3.829 | 4.738 | 1.965 | 0.515 | 0.676 | 0.472 | 0.651 |
| Short Term Debt
| 0 | 1.918 | 1.755 | 1.602 | 0.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0.78 | 0.753 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 22.262 | 26.825 | 0 | 0 | 0 | 1.452 | 3.475 | 0.393 | 0 |
| Other Current Liabilities
| 14.009 | 11.936 | 10.236 | 11.988 | 10.565 | 9.251 | 4.677 | 6.795 | 3.303 | 1.431 | 1.282 | 0.041 | 1.525 |
| Total Current Liabilities
| 25.592 | 23.458 | 17.616 | 18.483 | 42.894 | 40.447 | 8.506 | 11.533 | 5.268 | 3.398 | 5.433 | 1.686 | 2.929 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 37.079 | 1.918 | 1.918 | 3.673 | 3.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 15.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 6.088 | 9.604 | 0 | 0 | 0 | 1.562 | 1.718 | 1.57 | 0.585 | 0.874 | 1.139 | 1.412 | 1.652 |
| Total Non-Current Liabilities
| 43.167 | 11.522 | 1.918 | 3.673 | 3.352 | 16.746 | 1.718 | 1.57 | 0.585 | 0.874 | 1.139 | 1.412 | 1.652 |
| Total Liabilities
| 68.759 | 23.458 | 19.534 | 22.156 | 46.246 | 57.193 | 10.224 | 13.103 | 5.853 | 4.272 | 6.572 | 3.098 | 4.581 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55.934 | 65.586 | 60.572 | 58.168 |
| Common Stock
| 0.054 | 0.053 | 0.053 | 0.05 | 0.047 | 0.039 | 0.033 | 0.027 | 0.027 | 0.023 | 0.004 | 0.003 | 0.003 |
| Retained Earnings
| -684.745 | -566.232 | -480.758 | -392.317 | -400.727 | -294.354 | -220.341 | -162.171 | -104.891 | -80.201 | -62.456 | -59.384 | -53.113 |
| Accumulated Other Comprehensive Income/Loss
| -0.26 | -1.672 | -0.358 | 0.073 | 0.17 | -0.114 | -0.07 | 0.003 | -0.035 | -6.192 | -5.415 | -4.626 | -5.504 |
| Other Total Stockholders Equity
| 742.036 | 726.63 | 708.585 | 641.195 | 587.223 | 428.059 | 307.158 | 212.866 | 209.943 | 82.098 | 13.792 | 5.874 | 6.55 |
| Total Shareholders Equity
| 57.085 | 158.779 | 227.522 | 249.001 | 186.713 | 133.63 | 86.78 | 50.725 | 105.044 | 51.662 | 11.511 | 2.439 | 6.104 |
| Total Equity
| 57.085 | 158.779 | 227.522 | 249.001 | 186.713 | 133.63 | 86.78 | 50.725 | 105.044 | 51.662 | 11.511 | 2.439 | 6.104 |
| Total Liabilities & Shareholders Equity
| 125.844 | 182.237 | 247.056 | 271.157 | 232.959 | 190.823 | 97.004 | 63.828 | 110.897 | 55.934 | 18.083 | 5.537 | 10.685 |